Servicio Canario de la Salud

Organización

Artículos escritos por miembros del SESCS en 2016

Actualizado a: [27/05/2016]

Brito-García N, Del Pino-Sedeño T, Trujillo-Martín MM, Coco RM, Rodríguez de la Rúa E, Del Cura-González I, Serrano-Aguilar P. Effectiveness and safety of nutritional supplements in the treatment of hereditary retinal dystrophies: a systematic review. Eye (Lond). 2016 [Epub ahead of print]
Toledo-Chávarri A, Abt-Sacks A, Orrego C, Perestelo-Pérez L. El papel de la información escrita en el empoderamiento en salud: un estudio cualitativo. Panace@. 2016; 17(44):115-122
Vallejo-Torres L, García-Lorenzo B, Castilla I, Valcárcel-Nazco C, García-Pérez L, Linertová R, Serrano-Aguilar P. Estimación de un umbral coste-efectividad en España. ¿Cuánto nos cuesta generar salud?. Revista Española de Economía de la Salud. 2016; 11(3):404-409
Angelis A, Kanavos P, López-Bastida J, Linertová R, Serrano-Aguilar P; BURQOL-RD Research Network. Socioeconomic costs and health-related quality of life in juvenile idiopathic arthritis: a cost-of-illness study in the United Kingdom. BMC Musculoskelet Disord. 2016;17:321
Rosanova MT, Bes D, Serrano Aguilar P, Cuellar Pompa L, Sberna N, Lede R. Efficacy and safety of caspofungin in children: systematic review and meta-analysis. Arch Argent Pediatr. 2016; 114(4):305-12
Rosanova MT, Cuéllar-Pompa L, Perez G, Sberna N, Serrano-Aguilar P, Lede R. Is trimethoprim-sulfamethoxazole a valid alternative in the management of infections in children in the era of community-acquired methicillin-resistant Staphylococcus aureus? A comprehensive systematic review. Journal of Pharmacy Technology. 2016; 32(2):81-87
Del Cura-González I, López-Rodríguez JA, Sanz-Cuesta T, Rodríguez-Barrientos R, Martín-Fernández J, Trujillo-Martín M, et al.; Educaguia Group. Effectiveness of a strategy that uses educational games to implement clinical practice guidelines among Spanish residents of family and community medicine (e-EDUCAGUIA project): a clinical trial by clusters. Implement Sci. 2016; 11(1):71
Renata Linertová, Valcárcel-Nazco C, Posada-de-la-Paz M, López-Bastida J, Serrano-Aguilar P. Disability evaluation in patients with rare diseases in Spain: the importance of being in accord. BURQOL-RD Project. Rare diseases and orphan drugs. 2016; 3(1):5-10
Serrano-Aguilar P, Trujillo-Martin M, del Pino-Sedeño T, Pérez de la Rosa A, de Pascual y M, Perestelo-Pérez L, et al. Patient participation in the development of a clinical guideline for inherited retinal dystrophies. Expert Opinion on Orphan Drugs 2016;4(7):691-697
Castilla-Rodríguez I, Cela E, Vallejo-Torres L, Valcárcel-Nazco C, Dulín E, Espada M, Rausell D, Mar J, Serrano-Aguilar P. Cost-effectiveness analysis of newborn screening for sickle-cell disease in Spain. Expert Opinion on Orphan Drugs. 2016 [Epub ahead of print]
Angelis A, Kanavos P, López-Bastida J, Linertová R, Oliva-Moreno J, Serrano-Aguilar P, Posada-de-la-Paz M, Taruscio D, Schieppati A, Iskrov G, Brodszky V, von der Schulenburg JM, Chevreul K, Persson U, Fattore G; BURQOL-RD Research Network. Social/economic costs and health-related quality of life in patients with epidermolysis bullosa in Europe. Eur J Health Econ. 2016; 17 Suppl 1:31-42
Kuhlmann A, Schmidt T, Treskova M, López-Bastida J, Linertová R, Oliva-Moreno J, Serrano-Aguilar P, Posada-de-la-Paz M, Kanavos P, Taruscio D, Schieppati A, Iskrov G, Péntek M, Delgado C, von der Schulenburg JM, Persson U, Chevreul K, Fattore G; BURQOL-RD Research Network. Social/economic costs and health-related quality of life in patients with juvenile idiopathic arthritis in Europe. Eur J Health Econ. 2016; 17 Suppl 1:79-87
Chevreul K, Gandré C, Brigham KB, López-Bastida J, Linertová R, Oliva-Moreno J, Serrano-Aguilar P, Posada-de-la-Paz M, Taruscio D, Schieppati A, Iskrov G, Gulácsi L, von der Schulenburg JM, Kanavos P, Persson U, Fattore G; BURQOL-RD Research Network. Social/economic costs and health-related quality of life in patients with fragile X syndrome in Europe. Eur J Health Econ. 2016; 17 Suppl 1:43-52
Péntek M, Gulácsi L, Brodszky V, Baji P, Boncz I, Pogány G, López-Bastida J, Linertová R, Oliva-Moreno J, Serrano-Aguilar P, Posada-de-la-Paz M, Taruscio D, Iskrov G, Schieppati A, von der Schulenburg JM, Kanavos P, Chevreul K, Persson U, Fattore G; BURQOL-RD Research Network. Social/economic costs and health-related quality of life of mucopolysaccharidosis patients and their caregivers in Europe. Eur J Health Econ. 2016; 17 Suppl 1:89-98
Chevreul K, Michel M, Brigham KB, López-Bastida J, Linertová R, Oliva-Moreno J, Serrano-Aguilar P, Posada-de-la-Paz M, Taruscio D, Schieppati A, Iskrov G, Péntek M, von der Schulenburg JM, Kanavos P, Persson U, Fattore G; BURQOL-RD Research Network. Social/economic costs and health-related quality of life in patients with cystic fibrosis in Europe. Eur J Health Econ. 2016; 17 Suppl 1:7-18
Cavazza M, Kodra Y, Armeni P, De Santis M, López-Bastida J, Linertová R, Oliva-Moreno J, Serrano-Aguilar P, Posada-de-la-Paz M, Taruscio D, Schieppati A, Iskrov G, Gulácsi L, von der Schulenburg JM, Kanavos P, Chevreul K, Persson U, Fattore G; BURQOL-RD Research Network. Social/economic costs and quality of life in patients with haemophilia in Europe. Eur J Health Econ. 2016; 17 Suppl 1:53-65
Iskrov G, Astigarraga I, Stefanov R, López-Bastida J, Linertová R, Oliva-Moreno J, Serrano-Aguilar P, Posada-de-la-Paz M, Schieppati A, Taruscio D, Péntek M, von der Schulenburg JM, Kanavos P, Chevreul K, Persson U, Fattore G; BURQOL-RD Research Network. Social/economic costs and health-related quality of life in patients with histiocytosis in Europe. Eur J Health Econ. 2016; 17 Suppl 1:67-78
López-Bastida J, Linertová R, Oliva-Moreno J, Posada-de-la-Paz M, Serrano-Aguilar P, Kanavos P, Taruscio D, Schieppati A, Iskrov G, Baji P, Delgado C, von der Schulenburg JM, Persson U, Chevreul K, Fattore G; BURQOL-RD Research Network. Social/economic costs and health-related quality of life in patients with Prader-Willi syndrome in Europe. Eur J Health Econ. 2016; 17 Suppl 1:99-108
López-Bastida J, Linertová R, Oliva-Moreno J, Serrano-Aguilar P, Posada-de-la-Paz M, Kanavos P, Taruscio D, Schieppati A, Iskrov G, Péntek M, Delgado C, von der Schulenburg JM, Persson U, Chevreul K, Fattore G; BURQOL-RD Research Network. Social/economic costs and health-related quality of life in patients with scleroderma in Europe. Eur J Health Econ. 2016; 17 Suppl 1:109-117
Cavazza M, Kodra Y, Armeni P, De Santis M, López-Bastida J, Linertová R, Oliva-Moreno J, Serrano-Aguilar P, Posada-de-la-Paz M, Taruscio D, Schieppati A, Iskrov G, Péntek M, von der Schulenburg JM, Kanavos P, Chevreul K, Persson U, Fattore G; BURQOL-RD Research Network. Social/economic costs and health-related quality of life in patients with Duchenne muscular dystrophy in Europe. Eur J Health Econ. 2016; 17 Suppl 1:19-29
López-Bastida J, Oliva-Moreno J, Linertová R, Serrano-Aguilar P. Social/economic costs and health-related quality of life in patients with rare diseases in Europe. Eur J Health Econ. 2016; 17 Suppl 1:1-5
Vallejo-Torres L, García-Lorenzo B, Castilla I, Valcárcel-Nazco C, García-Pérez L, Linertová R, Polentinos-Castro E, Serrano-Aguilar P. On the estimation of the cost-effectiveness threshold: why, what, how?. Value in Health. 2016 [Epub ahead of print]
Linertová R, Valcárcel-Nazco C, Lacalle-Remigio JR. [Management of benign melanocytic lesions as a melanoma prevention. Systematic review]. Med Clin (Barc). 2016 [Epub ahead of print]
Bilbao A, Escobar A, García-Perez L, Navarro G, Quirós R. The Minnesota living with heart failure questionnaire: comparison of different factor structures. Health Qual Life Outcomes. 2016;14(1):23
Trujillo-Martín MM, Rúa-Figueroa Fernández de Larrinoa I, Ruíz-Irastorza G, Pego-Reigosa JM, Sabio Sánchez JM, Serrano-Aguilar P; en nombre del Grupo Elaborador de la GPC-LES. [Clinical practice guidelines for systemic lupus erythematosus: Recommendations for general clinical management]. Med Clin (Barc). 2016; 146(9):413.e1-413.e14
García-Pérez L, Abreu-González R, Pérez-Ramos J, García-Pérez S, Serrano-Aguilar P. Review of economic studies and budget impact analysis of ocriplasmin as a treatment of vitreomacular traction. Arch Soc Esp Oftalmol. 2016 [Epub ahead of print]